PMID- 11173851 OWN - NLM STAT- MEDLINE DCOM- 20010329 LR - 20171101 IS - 0301-0171 (Print) IS - 0301-0171 (Linking) VI - 91 IP - 1-4 DP - 2000 TI - Prenatal molecular cytogenetic diagnosis of partial tetrasomy 10p due to neocentromere formation in an inversion duplication analphoid marker chromosome. PG - 165-70 AB - Neocentromeres are fully functional centromeres found on rearranged or marker chromosomes that have separated from endogenous centromeres. Neocentromeres often result in partial tri- or tetrasomy because their formation confers mitotic stability to acentric chromosome fragments that would normally be lost. We describe the prenatal identification and characterization of a de novo supernumerary marker chromosome (SMC) containing a neocentromere in a 20-wk fetus by the combined use of comparative genomic hybridization (CGH) and fluorescence in situ hybridization (FISH). GTG-banding of fetal metaphases revealed a 47,XY,+mar karyotype in 100% of cultured amniocytes; parental karyotypes were both normal. Although sequential tricolor FISH using chromosome-specific painting probes identified a chromosome 10 origin of the marker, a complete panel of chromosome-specific centromeric satellite DNA probes failed to hybridize to any portion of the marker. The presence of a neocentromere on the marker chromosome was confirmed by the absence of hybridization of an all-human-centromere alpha-satellite DNA probe, which hybridizes to all normal centromeres, and the presence of centromere protein (CENP)-C, which is associated specifically with active kinetochores. Based on CGH analysis and FISH with a chromosome 10p subtelomeric probe, the marker was found to be an inversion duplication of the distal portion of chromosome 10p. Thus, the proband's karyotype was 47,XY,+inv dup(10)(pter-->p14 approximately 15::p14 approximately 15-->neo-->pter), which is the first report of partial tetrasomy 10p resulting from an analphoid marker chromosome with a neocentromere. This study illustrates the use of several molecular strategies in distinguishing centric alphoid markers from neocentric analphoid markers. CI - Copyright 2001 S. Karger AG, Basel FAU - Levy, B AU - Levy B AD - Department of Human Genetics, Mount Sinai School of Medicine, New York, NY 10029, USA. brynn.levy@mssm.edu FAU - Papenhausen, P AU - Papenhausen P FAU - Tepperberg, J AU - Tepperberg J FAU - Dunn, T AU - Dunn T FAU - Fallet, S AU - Fallet S FAU - Magid, M AU - Magid M FAU - Kardon, N AU - Kardon N FAU - Hirschhorn, K AU - Hirschhorn K FAU - Warburton, P AU - Warburton P LA - eng GR - 5 T32 HD07105-24/HD/NICHD NIH HHS/United States GR - R01-GM61150-01/GM/NIGMS NIH HHS/United States PT - Case Reports PT - Comparative Study PT - Journal Article PT - Research Support, Non-U.S. Gov't PT - Research Support, U.S. Gov't, P.H.S. PL - Switzerland TA - Cytogenet Cell Genet JT - Cytogenetics and cell genetics JID - 0367735 RN - 0 (DNA Probes) RN - 0 (DNA, Satellite) RN - 0 (Genetic Markers) SB - IM MH - Adult MH - Amniocentesis MH - *Aneuploidy MH - Centromere/*genetics MH - Chromosome Aberrations/*diagnosis/genetics MH - Chromosome Banding MH - Chromosome Disorders MH - *Chromosome Inversion MH - Chromosome Painting MH - Chromosomes, Human, Pair 10/*genetics MH - DNA Probes/genetics MH - DNA, Satellite/genetics MH - Female MH - *Gene Duplication MH - Genetic Markers/genetics MH - Humans MH - Karyotyping MH - Maternal Age MH - Pregnancy MH - Pregnancy, High-Risk MH - *Prenatal Diagnosis EDAT- 2001/02/15 11:00 MHDA- 2001/04/03 10:01 CRDT- 2001/02/15 11:00 PHST- 2001/02/15 11:00 [pubmed] PHST- 2001/04/03 10:01 [medline] PHST- 2001/02/15 11:00 [entrez] AID - 56839 [pii] AID - 10.1159/000056839 [doi] PST - ppublish SO - Cytogenet Cell Genet. 2000;91(1-4):165-70. doi: 10.1159/000056839.